Evidence map›Paper›PMID 33316927›Full record

ReviewInternational journal of molecular sciences2020

Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases.

Maite Martínez-Uña, Yaiza López-Mancheño, Carlos Diéguez, Manuel A Fernández-Rojo, Marta G Novelle

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Research Progress on Leptin in Metabolic Dysfunction-associated Fatty Liver Disease.Journal of clinical and translational hepatology · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maite Martínez-UñaHepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food (IMDEA-Food), CEI-UAM+CSIC, 28049 Madrid, Spain.
Yaiza López-MancheñoHepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food (IMDEA-Food), CEI-UAM+CSIC, 28049 Madrid, Spain.
Carlos DiéguezCenter for Research in Molecular Medicine and Chronic Diseases, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria (IDIS), 15782 Santiago de Compostela, Spain.
Manuel A Fernández-RojoHepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food (IMDEA-Food), CEI-UAM+CSIC, 28049 Madrid, Spain.ORCID 0000-0002-2240-1951
Marta G NovelleHepatic Regenerative Medicine Group, Madrid Institute for Advanced Studies in Food (IMDEA-Food), CEI-UAM+CSIC, 28049 Madrid, Spain.ORCID 0000-0003-0285-7182
Madrid Institute for Advanced Studies · ESUniversidade de Santiago de Compostela · ES

Funding

Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición CIBERComunidad de Madrid 2016/T1- BIO-1854Ministerio de Ciencia, Innovación y Universidades BFU2017-87721Xunta de Galicia 2019-2022- ED431G 2019/02
6 · The paper itself

Abstract

Since its discovery twenty-five years ago, the fat-derived hormone leptin has provided a revolutionary framework for studying the physiological role of adipose tissue as an endocrine organ. Leptin exerts pleiotropic effects on many metabolic pathways and is tightly connected with the liver, the major player in systemic metabolism. As a consequence, understanding the metabolic and hormonal interplay between the liver and adipose tissue could provide us with new therapeutic targets for some chronic liver diseases, an increasing problem worldwide. In this review, we assess relevant literature regarding the main metabolic effects of leptin on the liver, by direct regulation or through the central nervous system (CNS). We draw special attention to the contribution of leptin to the non-alcoholic fatty liver disease (NAFLD) pathogenesis and its progression to more advanced stages of the disease as non-alcoholic steatohepatitis (NASH). Likewise, we describe the contribution of leptin to the liver regeneration process after partial hepatectomy, the mainstay of treatment for certain hepatic malignant tumors.

Indexed as

Liver RegenerationAdipose TissueAnimalsHumansLeptinLiverNon-alcoholic Fatty Liver DiseaseLeptinadipose tissuehepatocarcinoma (HCC)leptinliver regenerationnon-alcoholic fatty liver disease (NAFLD)non-alcoholic steatohepatitis (NASH)partial hepatectomy

Identifiers

PMID33316927
PMCPMC7764544
OpenAlexW3112098306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.